NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (enExample) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (enExample) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (enExample)
CA (1) CA1040619A (enExample)
DE (1) DE2330342A1 (enExample)
DK (1) DK136157B (enExample)
FR (1) FR2189034B2 (enExample)
GB (1) GB1434919A (enExample)
LU (1) LU67790A1 (enExample)
NL (1) NL7308267A (enExample)
ZA (1) ZA734037B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
MY190408A (en) 2014-10-16 2022-04-21 Sage Therapeutics Inc Compositions and methods for treating cns disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
CA1040619A (en) 1978-10-17
ZA734037B (en) 1974-05-29
DK136157C (enExample) 1978-01-23
LU67790A1 (enExample) 1973-08-16
BE800899R (fr) 1973-12-14
FR2189034A2 (enExample) 1974-01-25
AU5693773A (en) 1974-12-19
DE2330342A1 (de) 1974-01-17
GB1434919A (en) 1976-05-12
FR2189034B2 (enExample) 1977-01-21
DK136157B (da) 1977-08-22

Similar Documents

Publication Publication Date Title
FR2189034A2 (enExample)
CS158170B2 (enExample)
FR2183847B1 (enExample)
FR2206516A1 (enExample)
JPS5233060B2 (enExample)
JPS4920879U (enExample)
JPS4962711A (enExample)
CS161039B1 (enExample)
JPS4932170U (enExample)
JPS5250659Y2 (enExample)
CS156890B1 (enExample)
CS151840B1 (enExample)
JPS4913613U (enExample)
JPS4991751U (enExample)
CS159522B1 (enExample)
CS156971B1 (enExample)
CS161013B1 (enExample)
CS157934B1 (enExample)
CH590341A5 (enExample)
CH568085A5 (enExample)
BG17866A1 (enExample)
CH578862A5 (enExample)
CH585385A5 (enExample)
CH562747A5 (enExample)
BG17922A1 (enExample)

Legal Events

Date Code Title Description
BV The patent application has lapsed